Litcius/Paper detail

Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial

Stefan Andreas, Marco Testa, Laurent Boyer, Guy Brusselle, Wim Janssens, Edward Kerwin, Alberto Papi, Bonavuth Pek, Luis Puente-Maestu, Dinesh Saralaya, Henrik Watz, Tom M A Wilkinson, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti, Ashwani K Arora, Ashwani K Arora, François Maltais, Guy Brusselle, Jean-Louis Corhay, Eduard Janssens, Wim Janssens, Mathias Leys, Murdo Ferguson, Mark Fitzgerald, François Maltais, Irvin Mayers, Shelly McNeil, Bonavuth Pek, Arnaud Bourdin, Laurent Boyer, Francis Couturaud, Luc Dussart, Stefan Andreas, Gabriele Illies, Andreas Eich, Andrea Ludwig-Sengpiel, Henrik Watz, Francesco Blasi, Stefano Centanni, Alberto Papi, Carlo Pomari, José Maria Echave-Sustaeta, Eleuterio Llorca Martínez, Silvia Narejos Pérez, Sergi Pascual-Guardia, Mercè Pérez Vera, Luis Puente-Maestu, Manuel Terns Riera, William Anderson, Gourab Choudhury, Anthony De-Soyza, Dinesh Saralaya, Tom MA Wilkinson, Joseph Boscia III, Kenneth Chinsky, Leonard Dunn, David Erb, Charles Fogarty, Herman Jackson Downey, Edward Kerwin, Craig Kunz, Terry Poling, Richard Sellman, Barry Sigal, John Southard, Selwyn Spangenthal, Ziad Tannous, Marco Testa, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti, Ashwani K Arora, Ashwani K Arora

2022The Lancet Respiratory Medicine30 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicinePulmonary diseaseHaemophilus influenzaeClinical trialMEDLINEImmunologyRespiratory tract infectionsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Phase (matter)Coronavirus disease 2019 (COVID-19)Pasteurellaceae2019-20 coronavirus outbreakCOPDPneumonia and Respiratory InfectionsBacterial Infections and VaccinesImmune responses and vaccinations
Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial | Litcius